Riaz Farookhi

Title: Riaz Farookhi: Innovator in Cell Adhesion and Cancer Therapy

Introduction

Riaz Farookhi is a prominent inventor based in Montreal, Canada. He has made significant contributions to the fields of cell adhesion and cancer therapy, holding a total of 5 patents. His work focuses on developing innovative compounds and methods that have the potential to impact medical science.

Latest Patents

Farookhi's latest patents include groundbreaking research on compounds and methods for modulating cell adhesion. One of his notable inventions involves cyclic peptides that comprise a cadherin cell adhesion recognition sequence HAV. These cyclic peptides are designed to modulate cadherin-mediated cell adhesion in various contexts. Additionally, he has developed agents that inhibit the development of cancer and tumor growth. These agents contain a classical cadherin CAR sequence HAV within a cyclic peptide ring, which may be utilized to prevent or treat cancer effectively.

Career Highlights

Riaz Farookhi is affiliated with McGill University, where he continues to advance his research and innovation. His work has garnered attention in the scientific community, contributing to the understanding of cell adhesion mechanisms and their implications in cancer therapy.

Collaborations

Farookhi collaborates with esteemed colleagues, including Orest W Blaschuk and Barbara J Gour. Their combined expertise enhances the research efforts and fosters a collaborative environment for innovation.

Conclusion

Riaz Farookhi's contributions to the fields of cell adhesion and cancer therapy exemplify his dedication to scientific advancement. His innovative patents and collaborative efforts position him as a key figure in medical research.